Yin Q, Wolkerstorfer A, Niessen FB, Gibbs S, Louter JMI, van Zuijlen PPM, Lapid O. Current Practice in Keloid Treatment: a Survey of Dutch Dermatologists and Plastic Surgeons.
Dermatol Surg 2023;
49:844-850. [PMID:
37389923 DOI:
10.1097/dss.0000000000003869]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/01/2023]
Abstract
BACKGROUND
Several therapeutic options are available for the treatment of keloids, but it remains unclear which treatment options are most commonly used by practitioners.
OBJECTIVE
To explore the prevailing treatment for different keloid phenotypes among dermatologists and plastic surgeons in the Netherlands.
METHODS
Members of the Dutch society for Plastic surgery and the Dutch society for Dermatology and Venereology were asked to participate. Questions elaborated on the treatment for a small and a large keloid on the mandibula and multiple keloids on the chest.
RESULTS
One hundred forty-three responses were obtained. Heterogeneity in treatment was extremely high for the small, large, and multiple keloids with 27, 35, and 33 various first choices, respectively. Intralesional corticosteroids were most often chosen for all 3 different keloid phenotypes. These were mostly (61%) administered as monotherapy for the small keloid and mostly combined with other treatments for the large keloid (19%) and multiple keloids (43%). Surgery was chosen regularly (22%) for the large keloid, mostly combined with intralesional corticosteroids (10%) or brachytherapy (8.4%).
CONCLUSION
Keloid treatment is very heterogeneous among dermatologists and plastic surgeons, even in a relatively small country as the Netherlands. Moreover, the treatment choice depends on the keloid phenotype.
Collapse